Dr Robert M Coleman, MD | |
3053 W State St, Bristol, TN 37620-1720 | |
(423) 968-1144 | |
(423) 968-3453 |
Full Name | Dr Robert M Coleman |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 32 Years |
Location | 3053 W State St, Bristol, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225079759 | NPI | - | NPPES |
30016543010001 | Medicaid | VA | |
1525730 | Medicaid | TN | |
00114726 | Medicaid | MS |
Facility Name | Location | Facility Type |
---|---|---|
Wellmont Holston Valley Medical Center | Kingsport, TN | Hospital |
Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
Greeneville Community Hospital | Greeneville, TN | Hospital |
Lonesome Pine Hospital | Big stone gap, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Blue Ridge Radiology Pc | 7416860473 | 38 |
Blue Ridge Radiology Pc | 7416860473 | 38 |
News Archive
Laura Cameron, then three months pregnant, tripped and fell in a parking lot and landed in the emergency room last May — her blood pressure was low and she was scared and in pain. She was flat on her back and plugged into a saline drip when a hospital employee approached her gurney to discuss how she would pay her hospital bill.
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
In a landmark study, researchers from Temple University School of Medicine will analyze whether the frequent monitoring and adjustment critical to the management of diabetes during pregnancy can be better accomplished by telemedicine.
Elekta and Royal Philips announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.
› Verified 5 days ago
Entity Name | Keystone Medical Services Of Ms Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174691059 PECOS PAC ID: 7618075177 Enrollment ID: O20070606000447 |
News Archive
Laura Cameron, then three months pregnant, tripped and fell in a parking lot and landed in the emergency room last May — her blood pressure was low and she was scared and in pain. She was flat on her back and plugged into a saline drip when a hospital employee approached her gurney to discuss how she would pay her hospital bill.
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
In a landmark study, researchers from Temple University School of Medicine will analyze whether the frequent monitoring and adjustment critical to the management of diabetes during pregnancy can be better accomplished by telemedicine.
Elekta and Royal Philips announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.
› Verified 5 days ago
Entity Name | Mississippi Emergency Physician Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710220678 PECOS PAC ID: 2264672492 Enrollment ID: O20130710000827 |
News Archive
Laura Cameron, then three months pregnant, tripped and fell in a parking lot and landed in the emergency room last May — her blood pressure was low and she was scared and in pain. She was flat on her back and plugged into a saline drip when a hospital employee approached her gurney to discuss how she would pay her hospital bill.
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
In a landmark study, researchers from Temple University School of Medicine will analyze whether the frequent monitoring and adjustment critical to the management of diabetes during pregnancy can be better accomplished by telemedicine.
Elekta and Royal Philips announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.
› Verified 5 days ago
Entity Name | Association Of University Radiologists, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619088697 PECOS PAC ID: 0749269785 Enrollment ID: O20180305001909 |
News Archive
Laura Cameron, then three months pregnant, tripped and fell in a parking lot and landed in the emergency room last May — her blood pressure was low and she was scared and in pain. She was flat on her back and plugged into a saline drip when a hospital employee approached her gurney to discuss how she would pay her hospital bill.
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
In a landmark study, researchers from Temple University School of Medicine will analyze whether the frequent monitoring and adjustment critical to the management of diabetes during pregnancy can be better accomplished by telemedicine.
Elekta and Royal Philips announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.
› Verified 5 days ago
Entity Name | Blue Ridge Radiology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881687689 PECOS PAC ID: 7416860473 Enrollment ID: O20211117001091 |
News Archive
Laura Cameron, then three months pregnant, tripped and fell in a parking lot and landed in the emergency room last May — her blood pressure was low and she was scared and in pain. She was flat on her back and plugged into a saline drip when a hospital employee approached her gurney to discuss how she would pay her hospital bill.
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
In a landmark study, researchers from Temple University School of Medicine will analyze whether the frequent monitoring and adjustment critical to the management of diabetes during pregnancy can be better accomplished by telemedicine.
Elekta and Royal Philips announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robert M Coleman, MD 3053 W State St, Bristol, TN 37620-1720 Ph: (423) 968-1144 | Dr Robert M Coleman, MD 3053 W State St, Bristol, TN 37620-1720 Ph: (423) 968-1144 |
News Archive
Laura Cameron, then three months pregnant, tripped and fell in a parking lot and landed in the emergency room last May — her blood pressure was low and she was scared and in pain. She was flat on her back and plugged into a saline drip when a hospital employee approached her gurney to discuss how she would pay her hospital bill.
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
In a landmark study, researchers from Temple University School of Medicine will analyze whether the frequent monitoring and adjustment critical to the management of diabetes during pregnancy can be better accomplished by telemedicine.
Elekta and Royal Philips announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.
› Verified 5 days ago
John E. Hutchison Jr., M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-968-1144 Fax: 423-968-3453 | |
Dr. Henry Austin Carr, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1009 Tween Hill Forest Trl, Bristol, TN 37620 Phone: 423-764-6287 Fax: 423-764-3210 | |
Richard R. Gentry, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-968-1144 Fax: 423-968-3453 | |
John A. Fincher, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-968-1144 Fax: 423-968-3453 | |
Dr. Jeffrey Stephen Alvis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3053 W State St, Bristol, TN 37620 Phone: 423-301-6567 | |
Jack M. Hoffnung, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-968-1144 Fax: 423-968-3453 |